“AbCellera Biologics Inc., a Canadian biotechnology startup that uses machine learning to develop antibody therapies, finds itself on the front lines of the Covidcampaign-pages/bispecifics/-19 global pandemic.”
Read full coverage on The Wall Street Journal.